BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 33125133)

  • 21. Role of Filamin A in Growth and Migration of Breast Cancer-Review.
    Zawadka P; Zielińska W; Gagat M; Izdebska M
    Curr Issues Mol Biol; 2024 Apr; 46(4):3408-3423. PubMed ID: 38666944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
    Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
    Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
    Sun GG; Wei CD; Jing SW; Hu WN
    Asian Pac J Cancer Prev; 2014; 15(8):3789-95. PubMed ID: 24870795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncoupling protein 2 is upregulated in melanoma cells and contributes to the activation of Akt/mTOR and ERK signaling.
    Li J; Jia Y; An L; Niu C; Cong X; Zhao Y
    Int J Oncol; 2020 May; 56(5):1252-1261. PubMed ID: 32319575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Zhang HR; Lai SY; Huang LJ; Zhang ZF; Liu J; Zheng SR; Ding K; Bai X; Zhou JY
    Gynecol Oncol; 2018 Apr; 149(1):188-197. PubMed ID: 29395313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of immune inhibitory molecule B7-H4 in cervical cancer.
    Han S; Li Y; Zhang J; Liu L; Chen Q; Qian Q; Li S; Zhang Y
    Oncol Rep; 2017 Apr; 37(4):2308-2316. PubMed ID: 28260085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasion.
    Sun GG; Lu YF; Zhang J; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3819-26. PubMed ID: 24390612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.
    Kim H; Park W; Kim YS; Kim YJ
    J Gynecol Oncol; 2020 May; 31(3):e35. PubMed ID: 31912685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
    CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer.
    Imai K; Fukuda T; Wada T; Kawanishi M; Tasaka R; Yasui T; Sumi T
    Oncol Lett; 2017 Jul; 14(1):951-957. PubMed ID: 28693257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FLNA is a predictor of chemoresistance and poor survival in cervical cancer.
    Jin YZ; Pei CZ; Wen LY
    Biomark Med; 2016 Jul; 10(7):711-9. PubMed ID: 27347840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
    Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer statistics in China, 2015.
    Chen W; Zheng R; Baade PD; Zhang S; Zeng H; Bray F; Jemal A; Yu XQ; He J
    CA Cancer J Clin; 2016; 66(2):115-32. PubMed ID: 26808342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylglyoxal Impairs Insulin Secretion of Pancreatic β-Cells through Increased Production of ROS and Mitochondrial Dysfunction Mediated by Upregulation of UCP2 and MAPKs.
    Bo J; Xie S; Guo Y; Zhang C; Guan Y; Li C; Lu J; Meng QH
    J Diabetes Res; 2016; 2016():2029854. PubMed ID: 26779540
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.